Respiratory and sleep Archives - Page 7 of 14

Podcasts

Current asthma management update – Lecture

Prof Dave Singh presents the key features to help identify those patients who need better control of their asthma.

Podcasts

COPD update

Prof Dave Singh highlights the key changes that have occurred with regard to COPD from a clinical perspective.

Podcasts

Asthma – Why do we need LAMAs – Lecture

Dr Kerry Hancock gives a very practical, case-based explanation of where LAMAs fit into a patient's asthma management.

Podcasts

Co-morbid insomnia and sleep apnoea

Recognise that insomnia and sleep apnoea do frequently co-occur. This is roughly 40-50% of patients with either condition, will have both...

Clinical Articles

Insomnia assessment and management podcast series

As insomnia and sleep disorders become more common, delve into our podcast series that highlights the recommendations to help treat patients with this condition.

Expert/s: Healthed

Videos

Fluticasone furoate/umeclidinium/vilanterol single inhaler triple therapy for the management of moderate to severe COPD

In this Product Explainer, Respiratory Physician Dr Martin MacDonald explains the role of single inhaler triple therapy containing fluticasone furoate/umeclidinium/vilanterol for the management of moderate to severe COPD (5 mins).

Videos

Olopatadine hydrochloride & mometasone furoate combination nasal spray for allergic rhinitis & rhinoconjunctivitis

In this Product Explainer, Rhinologist Prof Richard Harvey explains the role of olopatadine hydrochloride and mometasone furoate combination nasal spray in the treatment of symptoms associated with allergic rhinitis and rhinoconjunctivitis in patients 6 years of age and older (5 mins).

Podcasts

Obstructive sleep apnea and driving – Ausroads fitness to drive guidelines and the role of GPs

If a person presents with high level of sleepiness or setting them for sleep apnea, driving needs to be considered

Podcasts

COPD and triple therapy: When we should and shouldn’t use it – Your questions answered

The questions answered in this podcast are listed below. They were compiled by GPs and health professionals around Australia.

Clinical Articles

ICS for COPD – Understanding the risks and benefits

Triple therapy for COPD has very different risk/benefits compared to asthma.

Clinical Articles

Common GP emergencies: Asthma

A quick refresher on how to treat an asthma emergency.

Podcasts

Asthma, asthma pharmacology and lung function testing

Asthma needs to be diagnosed effectively. Need objective evidence for the presence of asthma and if it suggests it’s something there’s opportunity to escalate investigation to tertiary care

Respiratory and sleep

Current asthma management update – Lecture

Prof Dave Singh presents the key features to help identify those patients who need better control of their asthma.

COPD update

Prof Dave Singh highlights the key changes that have occurred with regard to COPD from a clinical perspective.

Asthma – Why do we need LAMAs – Lecture

Dr Kerry Hancock gives a very practical, case-based explanation of where LAMAs fit into a patient's asthma management.

Co-morbid insomnia and sleep apnoea

Recognise that insomnia and sleep apnoea do frequently co-occur. This is roughly 40-50% of patients with either condition, will have both...

Insomnia assessment and management podcast series

As insomnia and sleep disorders become more common, delve into our podcast series that highlights the recommendations to help treat patients with this condition.

Fluticasone furoate/umeclidinium/vilanterol single inhaler triple therapy for the management of moderate to severe COPD

In this Product Explainer, Respiratory Physician Dr Martin MacDonald explains the role of single inhaler triple therapy containing fluticasone furoate/umeclidinium/vilanterol for the management of moderate to severe COPD (5 mins).

Olopatadine hydrochloride & mometasone furoate combination nasal spray for allergic rhinitis & rhinoconjunctivitis

In this Product Explainer, Rhinologist Prof Richard Harvey explains the role of olopatadine hydrochloride and mometasone furoate combination nasal spray in the treatment of symptoms associated with allergic rhinitis and rhinoconjunctivitis in patients 6 years of age and older (5 mins).

Obstructive sleep apnea and driving – Ausroads fitness to drive guidelines and the role of GPs

If a person presents with high level of sleepiness or setting them for sleep apnea, driving needs to be considered

COPD and triple therapy: When we should and shouldn’t use it – Your questions answered

The questions answered in this podcast are listed below. They were compiled by GPs and health professionals around Australia.

ICS for COPD – Understanding the risks and benefits

Triple therapy for COPD has very different risk/benefits compared to asthma.

Common GP emergencies: Asthma

A quick refresher on how to treat an asthma emergency.

Asthma, asthma pharmacology and lung function testing

Asthma needs to be diagnosed effectively. Need objective evidence for the presence of asthma and if it suggests it’s something there’s opportunity to escalate investigation to tertiary care

Get the app

Site

Company

Connect

Legal

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

Respiratory and sleep

Prof Dave Singh presents the key features to help identify those patients who need better control of their asthma.

Prof Dave Singh highlights the key changes that have occurred with regard to COPD from a clinical perspective.

Dr Kerry Hancock gives a very practical, case-based explanation of where LAMAs fit into a patient's asthma management.

Recognise that insomnia and sleep apnoea do frequently co-occur. This is roughly 40-50% of patients with either condition, will have both...

As insomnia and sleep disorders become more common, delve into our podcast series that highlights the recommendations to help treat patients with this condition.

In this Product Explainer, Respiratory Physician Dr Martin MacDonald explains the role of single inhaler triple therapy containing fluticasone furoate/umeclidinium/vilanterol for the management of moderate to severe COPD (5 mins).

In this Product Explainer, Rhinologist Prof Richard Harvey explains the role of olopatadine hydrochloride and mometasone furoate combination nasal spray in the treatment of symptoms associated with allergic rhinitis and rhinoconjunctivitis in patients 6 years of age and older (5 mins).

If a person presents with high level of sleepiness or setting them for sleep apnea, driving needs to be considered

The questions answered in this podcast are listed below. They were compiled by GPs and health professionals around Australia.

Triple therapy for COPD has very different risk/benefits compared to asthma.

A quick refresher on how to treat an asthma emergency.

Asthma needs to be diagnosed effectively. Need objective evidence for the presence of asthma and if it suggests it’s something there’s opportunity to escalate investigation to tertiary care

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Extra Details

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.